fda semaglutide compounding enforcement october 2025 September 2, 2025: U.S. restrictions have stemmed a flood of compounded and tirzepatide – Partnership for Safe Medicines Congress Introduces SAFE Drugs Act

Visual problems (angle-closure glaucoma)

Analytic Approach To identify the major predictions shaping the 2026 health economy, a structured literature review was conducted, searching publicly available prediction articles published between November and December 2025

15 For a compounder, this creates significant business risk

Additionally, Canada, Spain, Germany, and Italy are mentioned multiple times, indicating their significant contribution to the body of research in this field

GLP-1 receptor agonists work by activating the GLP-1 receptors, which stimulate insulin secretion and decrease glucagon release, leading to better glycemic control

This segment is driving demand for medically guided nutrition aligned with weight loss and glycemic control needs